Dalbavancin in real life: Economic impact of prescription timing in French hospitals
View ORCID ProfileGuillaume Béraud, Jean-Claude Maupetit, Audric Darras, Alexandre Vimont, Martin Blachier
doi: https://doi.org/10.1101/2021.07.24.21259935
Guillaume Béraud
1Department of Internal Medicine and Infectious Diseases, University Hospital of Poitiers, Poitiers, France
Jean-Claude Maupetit
2Hospital pharmacy, University Hospital of Nantes, Nantes, France
Audric Darras
3UNIHA Tender, Hospital pharmacy, University Hospital of Toulouse, Toulouse, France
Alexandre Vimont
4Public Health Expertise, Paris
Martin Blachier
4Public Health Expertise, Paris
Posted July 28, 2021.
Dalbavancin in real life: Economic impact of prescription timing in French hospitals
Guillaume Béraud, Jean-Claude Maupetit, Audric Darras, Alexandre Vimont, Martin Blachier
medRxiv 2021.07.24.21259935; doi: https://doi.org/10.1101/2021.07.24.21259935
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12749)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4586)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4358)
- Nursing (236)
- Nutrition (639)
- Oncology (2270)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)